Grupo de investigación cardiovascular
GRINCAR
University Hospital of Bern
Berna, SuizaPublicaciones en colaboración con investigadores/as de University Hospital of Bern (7)
2021
-
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure
New England Journal of Medicine, Vol. 384, Núm. 2, pp. 105-116
2020
-
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials
European Journal of Heart Failure, Vol. 22, Núm. 11, pp. 2160-2171
2019
-
Prevalence of Medication Nonadherence to Co-medication Compared to Immunosuppressants in Heart Transplant Recipients: Findings From the International Cross-sectional BRIGHT Study
Clinical Therapeutics, Vol. 41, Núm. 1, pp. 130-136
2017
-
Heart transplant centers with multidisciplinary team show a higher level of chronic illness management – Findings from the International BRIGHT Study
Heart and Lung, Vol. 46, Núm. 5, pp. 351-356
2016
-
Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II
European Heart Journal, Vol. 37, Núm. 33, pp. 2591-2601
2015
-
Performance of gene-expression profiling test score variability to predict future clinical events in heart transplant recipients
BMC Cardiovascular Disorders, Vol. 15, Núm. 1
2011
-
Report from a consensus conference on antibody-mediated rejection in heart transplantation
Journal of Heart and Lung Transplantation, Vol. 30, Núm. 3, pp. 252-269